A RANDOMIZED TRIAL TO EVALUATE THE EFFECT OF SCHEDULE ON THE ACTIVITY OF ETOPOSIDE IN SMALL-CELL LUNG-CANCER

被引：420

作者：

SLEVIN, ML

CLARK, PI

JOEL, SP

MALIK, S

OSBORNE, RJ

GREGORY, WM

LOWE, DG

REZNEK, RH

WRIGLEY, PFM

机构：

[1] ST BARTHOLOMEWS HOSP,DEPT HISTOPATHOL,LONDON EC1A 7BE,ENGLAND

[2] ST BARTHOLOMEWS HOSP,DEPT DIAGNOST RADIOL,LONDON EC1A 7BE,ENGLAND

[3] HOMERTON HOSP,LONDON,ENGLAND

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 09期

关键词：

D O I：

10.1200/JCO.1989.7.9.1333

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1333 / 1340

页数：8

共 32 条

[1] CELL-CYCLE STAGE-DEPENDENT INDUCTION OF G2 PHASE ARREST BY DIFFERENT ANTI-TUMOR AGENTS [J].

BARLOGIE, B ;

DREWINKO, B .

EUROPEAN JOURNAL OF CANCER, 1978, 14 (07) :741-745

[2] TENIPOSIDE (VM-26), AN OVERLOOKED HIGHLY-ACTIVE AGENT IN SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL IN UNTREATED PATIENTS [J].

BORK, E ;

HANSEN, M ;

DOMBERNOWSKY, P ;

HANSEN, SW ;

PEDERSEN, AG ;

HANSEN, HH .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :524-527

[3]

CAVALLI F, 1978, CANCER TREAT REP, V62, P473

[4] INVITRO CYTO-TOXICITY OF VP-16 ON PRIMARY TUMOR AND METASTASIS OF LEWIS LUNG-CARCINOMA [J].

DINCALCI, M ;

ERBA, E ;

VAGHI, M ;

MORASCA, L .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (04) :377-380

[5]

DOMBERNOWSKY P, 1973, ACTA PATH MICRO IM A, VA 81, P715

[6]

DREWINKO B, 1976, CANCER TREAT REP, V60, P1295

[7]

EDMUNDSON J, 1983, BRIT J CANCER, V48, P114

[8]

GRECO FA, 1985, SEMIN ONCOL, V12, P42

[9]

GRIEDER A, 1974, CANCER RES, V34, P1788

[10] VARIABLE BIOAVAILABILITY FOLLOWING REPEATED ORAL DOSES OF ETOPOSIDE [J].

HARVEY, VJ ;

SLEVIN, ML ;

JOEL, SP ;

SMYTHE, MM ;

JOHNSTON, A ;

WRIGLEY, PFM .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (11) :1315-1319

← 1 2 3 4 →